Your browser doesn't support javascript.
loading
Safety, tolerability, pharmacokinetics and effects of diet on AD16, a novel neuroinflammatory inhibitor for Alzheimer's disease: a randomized phase 1 study.
Peng, Daizhuang; Xu, Sumei; Zou, Ting; Wang, Yahui; Ouyang, Wenjuan; Zhang, Yalan; Dong, Chengmei; Li, Dai; Guo, Jie; Shen, Qiuying; Hu, Xiaolei; Zhou, Wenzhi; Li, Xiaomin; Qin, Qun.
Afiliación
  • Peng D; National Institution of Drug Clinical Trial, Xiangya Hospital, Central South University, Changsha, 410008, China.
  • Xu S; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, 410008, China.
  • Zou T; International Science and Technology Innovation Cooperation Base for Early Clinical Trials of Biological Agents in Hunan Province, Changsha, China.
  • Wang Y; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, 410008, China.
  • Ouyang W; Phase I Clinical Research Center, Xiangya Hospital, Central South University, Changsha, China.
  • Zhang Y; National Institution of Drug Clinical Trial, Xiangya Hospital, Central South University, Changsha, 410008, China.
  • Dong C; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, 410008, China.
  • Li D; The South China Center for Innovative Pharmaceuticals, Guangzhou, China.
  • Guo J; Xiangya Changde Hospital, Central South University, Changde, China.
  • Shen Q; First People's Hospital of Chongqing Liangjiang New Area, Chongqing, China.
  • Hu X; National Institution of Drug Clinical Trial, Xiangya Hospital, Central South University, Changsha, 410008, China.
  • Zhou W; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, 410008, China.
  • Li X; International Science and Technology Innovation Cooperation Base for Early Clinical Trials of Biological Agents in Hunan Province, Changsha, China.
  • Qin Q; National Institution of Drug Clinical Trial, Xiangya Hospital, Central South University, Changsha, 410008, China.
BMC Med ; 21(1): 459, 2023 11 23.
Article en En | MEDLINE | ID: mdl-37996817
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad de Alzheimer Límite: Adult / Humans Idioma: En Revista: BMC Med Asunto de la revista: MEDICINA Año: 2023 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad de Alzheimer Límite: Adult / Humans Idioma: En Revista: BMC Med Asunto de la revista: MEDICINA Año: 2023 Tipo del documento: Article País de afiliación: China